Brain Scientific Inc. Share Price
Equities
BRSF
US10488W2089
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | -31.82% | -.--% | -.--% |
2023 | Brain Scientific Inc. cancelled the acquisition of IMAC Holdings, Inc.. | CI |
2023 | Brain Scientific Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | 0.27 21.18 | Sales 2022 | 0.21 17.1 | Capitalization | 10.54M 840M |
---|---|---|---|---|---|
Net income 2021 | -9M -717M | Net income 2022 | -12M -957M | EV / Sales 2021 | 86,282,570 x |
Net Debt 2021 | 9.87M 786M | Net Debt 2022 | 2.12M 169M | EV / Sales 2022 | 58,984,517 x |
P/E ratio 2021 |
-0.88
x | P/E ratio 2022 |
-0.66
x | Employees | 11 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 70.66% |
1 day | -31.82% |
Managers | Title | Age | Since |
---|---|---|---|
Hassan Kotob
CEO | Chief Executive Officer | 61 | 30/09/21 |
Director of Finance/CFO | 62 | 30/09/21 | |
Daniel Cloutier
BRD | Director/Board Member | 59 | 14/11/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hassan Kotob
CEO | Chief Executive Officer | 61 | 30/09/21 |
Nickolay Kukekov
BRD | Director/Board Member | 49 | 20/09/18 |
Tom Olivier
BRD | Director/Board Member | 56 | 14/11/21 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 932K | |
+7.84% | 218B | |
+7.35% | 183B | |
+13.04% | 134B | |
+26.03% | 106B | |
-1.33% | 61.12B | |
+4.81% | 50.89B | |
+0.30% | 40.3B | |
+2.78% | 35.53B | |
+26.14% | 32.05B |
- Stock Market
- Equities
- BRSF Stock